Alx Oncology Holdings Inc’s recently made public that its PRESIDENT & CSO Pons Jaume unloaded Company’s shares for reported $0.71 million on Apr 16 ’24. In the deal valued at $14.20 per share,50,000 shares were sold. As a result of this transaction, Pons Jaume now holds 604,205 shares worth roughly $9.37 million.
Then, Pons Jaume sold 20,000 shares, generating $223,036 in total proceeds. Upon selling the shares at $11.15, the PRESIDENT & CSO now owns 628,359 shares.
Before that, Lettmann Jason bought 4,400 shares. Alx Oncology Holdings Inc shares valued at $49,771 were divested by the CHIEF EXECUTIVE OFFICER at a price of $11.31 per share. As a result of the transaction, Lettmann Jason now holds 171,620 shares, worth roughly $2.66 million.
Stifel downgraded its Alx Oncology Holdings Inc [ALXO] rating to a Hold from a a Buy in a research note published on March 08, 2024; the price target was increased to $14 from $10. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in early December from “a Hold” to “a Buy”. Jefferies also remained covering ALXO and has decreased its forecast on December 22, 2021 with a “Hold” recommendation from previously “Buy” rating. Stifel started covering the stock on September 30, 2021. It rated ALXO as “a Buy”.
Price Performance Review of ALXO
On Tuesday, Alx Oncology Holdings Inc [NASDAQ:ALXO] saw its stock jump 8.92% to $15.50. Over the last five days, the stock has gained 6.97%. Alx Oncology Holdings Inc shares have risen nearly 4.10% since the year began. Nevertheless, the stocks have risen 158.33% over the past one year. While a 52-week high of $17.42 was reached on 02/15/24, a 52-week low of $3.94 was recorded on 04/03/24. SMA at 50 days reached $13.64, while 200 days put it at $9.96. A total of 0.44 million shares were traded, compared to the trading of 0.29 million shares in the previous session.
Levels Of Support And Resistance For ALXO Stock
The 24-hour chart illustrates a support level at 14.49, which if violated will result in even more drops to 13.49. On the upside, there is a resistance level at 16.13. A further resistance level may holdings at 16.77. The Relative Strength Index (RSI) on the 14-day chart is 61.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.47, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 24.44%. Stochastics %K at 70.22% indicates the stock is a holding.
